The HMA is a network of heads of the National Competent Authorities (NCA) whose organisations are responsible for the regulations of medicinal products for human and veterinary use in the European Economic Area. The HMA co-operates with the European Medicines Agency (EMA) and the European Commission in the operation of the European medicines regulatory network and it is a unique model for cooperation and work sharing on statutory as well as voluntary regulatory activities. The NCAs are responsible for the authorisation of many of the medicines available in Europe that are not authorised by the European Commission on the recommendation of the European Medicines Agency. The Malta Medicines Authority will be also organising an HMA human stakeholders´ meeting in conjunction to the first meeting of the HMA. The human stakeholders´ meeting will be hosted with the respective EU Industry umbrella organizations representing pharmaceutical industry including the EU associations of health care professionals and patients.